SLPSystematic ReviewAmerican journal of speech-language pathology2022

Effectiveness of Interventions for Dysphagia in Parkinson Disease: A Systematic Review.

Pooja Gandhi, Catriona M Steele

PMID 34890260

WHAT IT FOUND

Across 26 studies of swallowing treatments in Parkinson's disease, results were inconsistent and the evidence too weak to recommend any specific intervention.

A few studies saw faster swallowing or less residue, but the quality of the data does not support choosing one treatment over another.

Key findings

01Results were inconsistent across all three intervention categories (pharmacological, neurostimulation, behavioral), and the overall quality of the evidence was low due to high risk of bias and poor instrumental rigor in the included studies.

02Low certainty evidence suggested a trend toward improved swallowing efficiency (timing, residue) but little effect on swallowing safety (penetration-aspiration, aspiration).

0322 of 27 study assessments were rated high risk of bias, and none of the 10 studies that reported on participant selection used random selection from an eligible pool.

STILL TO COME

How it was doneWhat they foundWhat it means for SLPs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

22 of 27 included study assessments were rated high risk of bias; none of the 10 studies that reported on participant selection used random selection. Mild baseline swallowing impairment was common, which may have created a ceiling effect that hid real improvements. Several studies tested only a single bolus or a single consistency, limiting how well they capture real-world swallowing. 10 of 20 studies with multiple raters did not report interrater reliability, making it hard to trust the scoring. Heterogeneity in VFSS, FEES, and EMG protocols across studies made pooling impossible, so no overall effect estimate exists. All included studies were single-center, and the review excluded manometry, qualitative data, and single-arm studies. The Evidence Project risk-of-bias tool does not capture some domains (participant blinding, selective reporting) that the Cochrane tool assesses.

Declared interests

Funded by NIDCD Grant R01DC011020 (NIH extramural), awarded to Catriona M. Steele. No industry funding or conflicts of interest declared.

The easy way to misread this

Do not read the trend toward faster swallowing or less residue as evidence that any specific treatment works. The review rates 22 of 27 included studies as high risk of bias, found no study used random participant selection, and concludes the evidence is too low in certainty to guide practice.

Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →